Stroke Rehabilitation Biodesign Workshop

Kerr, A. (Organiser)

Biomedical Engineering

Activity: Participating in or organising an event types › Participation in workshop, seminar, course

Description

Agenda

09:30 - Registration

10:00 - Welcome and introduction to the SIG, Dr Charlie Winkworth-Smith, KTN

10:10 - Neurorehabilitation state of the art, Prof Valerie Pomeroy, University of East Anglia

10:35 - Barriers to adoption and engagement with Users, Dr Andy Kerr, University of Strathclyde

11:00 - A user’s perspective

11:20 - Refreshments and networking

11:50 Vagal nerve stimulation, Prof Jesse Dawson, University of Glasgow

12:15 Transcranial Direct Current Stimulation (tDCS), Prof Madeleine Grealy, University of Strathclyde

12:40 Brain-Computer Interfaces and an Entrepreneurial Perspective, Prof Damien Coyle, NeuroCONCISE and Ulster University

13:05 Lunch and networking

14:05 Workshop session

15:50 Closing remarks

16:00 Refreshments and networking

Period	27 Feb 2020
Event type	Workshop
Location	Glasgow, United Kingdom
Degree of Recognition	National

Documents & Links

Stroke is the main cause of disability in adults. Recovery from the neurological damage of a stroke is predicated on the adaptive capacity of the central nervous system. This neuroplastic process can be enhanced through intensive task specific practice, stimulating environments, cognitive engagement and aerobic exercise. Evidence from repeated observational studies indicate a general inability in the UK to deliver this standard of therapy through existing models. There is then a clear argument for the more widespread adoption of technologies to support delivery of rehabilitation to stroke survivors. These technologies should be consistent with the principles of neuroplasticity, address the need to motivate and be widely accessible, including deployment in home and community environments. Recent advances in brain-computer interfaces, robotics and brain and muscular electrical stimulation have the potential to significantly improve rehabilitation and will have the greatest chance of success when tailored to meet the needs of individual patients and used in combination. The KTN’s Neurotechnology Special Interest Group is holding the third in its series of biodesign workshops in collaboration with the University of Strathclyde. The workshop aims to bring together clinicians, companies, academics, charities and other stakeholders, to accelerate the development of new neurotechnologies for stroke rehabilitation.